Adamas scores $40M, Navy funds to tackle the flu
Adamas Pharmaceuticals, one of Mohr Davidow Ventures‘ key life science investments, has raised $40 million in a fourth round of funding to develop antiviral treatments for the flu virus. Based in Emeryville, Calif., the company also just signed a research agreement with the U.S. Navy… Continue Reading
MDV hires pros to find personalized medicine investments
Mohr Davidow Ventures, a Menlo Park, Calif. firm, has hired two biotech experts to help it make prudent investments in personalized healthcare companies. Essentially, they will look for startups that apply technology to give patients more control over their medical experiences, and to cut costs… Continue Reading